The safety of magnetic resonance imaging in patients with programmable implanted intrathecal drug delivery systems: A 3-year prospective study

Anesthesia and Analgesia

Volumn 112, Issue 5, 2011, Pages 1124-1129

  De Andres, Jose ^a   Villanueva, Vicente ^a   Palmisani, Stefano ^a,b,c   Cerda Olmedo, German ^a   Lopez Alarcon, Maria Dolores ^a   Monsalve, Vicente ^a   Minguez, Ana ^a   Martinez Sanjuan, Vicente ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CATHETERIZATION; CLINICAL ARTICLE; DRUG DELIVERY SYSTEM; HEMODYNAMIC MONITORING; HUMAN; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; TELEMETRY;

EID: 79955478490     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e318210d017     Document Type: Article

References (16)

1. Thimineur MA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study. Pain 2004;109:242-9 (Pubitemid 38638700)
2. Miele VJ, Price KO, Bloomfield S, Hogg J, Bailes JE. A review of intrathecal morphine therapy related granulomas. Eur J Pain 2006;10:251-61 (Pubitemid 43255212)
3. De Andres J, Valia JC, Cerda-Olmedo G, Quiroz C, Villanueva V, Martinez-Sanjuan V, de Leon-Casasola O. Magnetic resonance imaging in patients with spinal neurostimulation systems. Anesthesiology 2007;106:779-86 (Pubitemid 46555622)
4. Shellock FG, Crues JV. MR procedures: biologic effects, safety, and patient care. Radiology 2004;232:635-52 (Pubitemid 39100245)
5. Schueler BA, Parrish TB, Lin JC, Hammer BE, Pangrle BJ, Ritenour ER, Kucharczyk J, Truwit CL. MRI compatibility and visibility assessment of implantable medical devices. J Magn Reson Imaging 1999;9:596-603 (Pubitemid 29194300)
6. von Roemeling R, Lanning RM, Eames FA. MR imaging of patients with implanted drug infusion pumps. J Magn Reson Imaging 1991;1:77-81
7. Shellock FG, Crivelli R, Venugopalan R. Programmable infusion pump and catheter: evaluation using 3-tesla magnetic resonance imaging. Neuromodulation 2008;11:163-70 (Pubitemid 352000327)
8. Magill ST, Wang P, Eller JL, Burchiel KJ. Differentiating intrathecal catheter tip granulomas from normal magnetic resonance image distortion caused by metallic catheter tips. Neurosurgery 2008;62:242-8 (Pubitemid 351640351)
9. Deer TR, Raso LJ, Coffey RJ, Allen JW. Intrathecal baclofen and catheter tip inflammatory mass lesions (granulomas): a reevaluation of case reports and imaging findings in light of experimental, clinicopathological, and radiological evidence. Pain Med 2008;9:391-5 (Pubitemid 351722511)
10. Sawyer-Glover AM, Shellock FG. Pre-MRI procedure screening: recommendations and safety considerations for biomedical implants and devices. J Magn Reson Imaging 2000;12: 92-106 (Pubitemid 30437269)
11. Baker KB, Nyenhuis JA, Hrdlicka G, Rezai AR, Tkach JA, Shellock FG. Neurostimulation systems: assessment of magnetic field interactions associated with 1.5- and 3-tesla MR systems. J Magn Reson Imaging 2005;21:72-7 (Pubitemid 40041423)
12. Baker KB, Tkach JA, Nyenhuis JA, Phillips M, Shellock FG, Gonzalez-Martinez J, Rezai AR. Evaluation of specific absorption rate as a dosimeter of MRI-related implant heating. J Magn Reson Imaging 2004;20:315-20 (Pubitemid 38970942)
13. Bourland JD, Nyenhuis JA, Schaefer DJ. Physiologic effects of intense MR imaging gradient fields. Neuroimaging Clin N Am 1999;9:363-77 (Pubitemid 29263864)
14. Shellock FG, Woods TO, Crues JV III. MR labeling information for implants and devices: explanation of terminology. Radiology 2009;253:26-30
15. Coffey RJ, Owens ML, Broste SK, Dubois MY, Ferrante FM, Schultz DM, Stearns LJ, Turner MS. Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain. Anesthesiology 2009;111: 881-91
16. Wen H, Denison TJ, Singerman RW, Balaban RS. The intrinsic signal-to-noise ratio in human cardiac imaging at 1.5, 3, and 4 T. J Magn Reson 1997;125:65-71 (Pubitemid 127451351)